Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-07-22

Clinical Trial Update: Cysteamine Eye Drops to Treat Corneal Crystals in Cystinosis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update reports results for cysteamine ophthalmic drops aimed at reducing corneal crystals in patients with cystinosis; the study is com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cysteamine eye drops (cysteamine)

Snippet

Sponsor: National Eye Institute (NEI) | Conditions: Cystinosis | Phase 2 | Status: COMPLETED | Results posted: 2014-07-22